Announcements Trials

Browse Landscape

Status

Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cisplatin 516 Radiotherapy 378 Cyclophosphamide 368 Carboplatin 359 Capecitabine 341 Paclitaxel 336 Oxaliplatin 335 Gemcitabine 323 Docetaxel 316 Fluorouracil 289 Drug Therapy 276 apatinib 247 Bevacizumab 247 camrelizumab 219 Etoposide 201 Irinotecan 181 Doxorubicin 181 Leucovorin 163 Dexamethasone 161 pembrolizumab 153 Neoadjuvant Therapy 146 sintilimab 145 Blood Specimen Collection 140 anlotinib 139 Pemetrexed 138 Cytarabine 138 toripalimab 134 Surgical Procedures, Operative 131 Radiosurgery 130 S 1 (combination) 125

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Vitrification × Clear all

NCT03680937 2018-09-21

OVOMIV

University Hospital, Clermont-Ferrand

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡